2 Cancer in Leicestershire, Annual Report of the Director of Public Health 1995/1996

Leicestershire Health. Leicester: 1996

3 Grannis F. History of Cigarette Smoking and lung cancer.

4 Lindsey Jarvis, Office for National Statistics. Smoking among secondary school children in 1996: England. London: The Stationery Office, 1997

6 Underwood J, Britton R. General and systematic pathology. Edinburgh: Churchill Livingstone, 1992.

7 McGee, Isaacson P, Wright N. Oxford textbook of pathology. Oxford: Oxford University Press, 1992.

8 WHO Histological Typing of lung cancers 2^nd ed. 1981Geneva/London

9 Shepherd FA. Alternatives to chemotherapy and radiotherapy as adjuvant treatment for lung cancer. lung cancer. 1997; 17(1): S121-S136.

10 Weller M. Insurance, reinsurance and underwriting names' liability for asbestos-related diseases. Medicine, Science & the Law. 1992; 32(1): 23-34.

11 Roland M, Rudd R. Genetics and pulmonary medicine – 7: Somatic mutations in the development of lung cancer, Thorax 1998; 53(11):979-983

12 Harris CC Chemical and physical carcinogenesis: from animal models to molecular models in one decade. Adv Cancer Res 1988; 50:25-70

13 Barbacid M. ras genes. Annu Rev Biochem 1987; 56:779-827

14 Bouck N. Tumour angiogenesis: the role of oncogenes and tumour suppressor genes. Cancer Cells 1990; 2:179-185

15 Liotta LA, Stegg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991;64:327-336

16 Hollstein M, Sidransky D, Vogelstein B, Harris CC. P53 mutations in human cancers. Science 1991; 253:49-53

17 Takashi T, Takashi H, Suzuki H et al. The p53 gene is frequently mutated in small-cell lung cancer with a distant nucleotide substitution pattern. Oncogene 1990; 6:1775-8

18 Chiba I, Takashi T, Nau MM et al. Mutations in the p53 gene are frequent in primary, resected non-small-cell lung cancer. Oncogene 1990; 5:1603-10

20 Lee J, Mao L, Hong W. Biology of preneoplastic lesions. In: Roth J, Cox J, Hong W eds. lung cancer 2^nd Ed. Oxford: Blackwell Science, 1998

21 Cox G, Steward P, O’Byrne K. The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer. Thorax 1999; 54:169-179

22 Muller F. Tobacco Misuse and Lung carcinoma. University of Cologne’s Pathological Institute, 1939

23 Levin M, Goldstein H, Gerhardt P. Cancer and Tobacco Smoking: A preliminary Report. JAMA 1950; 143(4):336-38

24 Wynder E, Graham E. Tobacco smoking as a possible etiological factor in bronchogenic carcinoma: A study of 684 proved cases. JAMA 1950; 143(4):329-36

25 Doll R, Hill AB. Smoking and Carcinoma of the lung. BMJ 1950; ii:739-48

26 Doll R, Hill AB. Mortality in relation to smoking. 10 years observations of British doctors. BMJ 1964; i:1399-410,1460-7

27 Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years’ observations on male British doctors. BMJ 1994; 309:901-911

28 Hackshaw A, Law M, Wald N. The accumulated evidence on lung cancer and environmental tobacco smoke. BMJ 1997; 315:980-988

29 Copas J, Shi J. Reanalysis of epidemiological evidence on lung cancer and passive smoking. BMJ 2000; 320:417-418

30 Williams C. lung cancer: The facts. Oxford: Oxford University Press, 1992.

31 Albin M, Magnani C, Krstev S, Rapiti E, Shefer I. Asbestos and cancer: An overview of current trends in Europe. Environ Health Perspect. 1999; 107(supplement 2):289-98

33 Kunitoh H. Sekine I. Kubota K et al. Histologic types of lung carcinoma and related family history of anatomic sites and histologic types of cancers. Cancer 1999; 86(7):1182-8

34 Parkin D ed. Cancer incidence in five continent. vol 7. Lyon: International Agency for Research on Cancer, 1997

35 Parkin D, Pisani P, Ferlay J. Estimates of the worldwide incidence of twenty-five major cancers in 1990. Int J Cancer: 1999; 80:827-841

36 Pisani P Parkin D, Bray F, Ferlay J. Estimates of the worldwide mortality from twenty-five major cancers in 1990. Int J Cancer 1999; 83:18-29

37 Botha H, Bright N, Needham P, Silcocks P. Trent cancer registry, Third annual report. Sheffield: Trent Cancer Registry, 1999.

38 Mortality rates from lung cancer, 2000. Unpublished data obtained from the Trent Cancer Registry.

39 Department of Health. Saving Lives: Our Healthier Nation. London: HMSO, 1999

40 Department of Health. Smoking kills: a white paper on tobacco, London: HMSO, 1998

41 Department of Health. The health of the nation: a strategy for health in England. London: HMSO, 1992.

42 Kumar P, Clark M. Clinical medicine : a textbook for medical students and doctors. 4th ed. Edinburgh: W.B. Saunders, 1998.

43 Dalmau J, Posner B. Paraneoplastic Syndromes. Arch Neurol 1999; 56(4): 405-408

44 Antoine J, Absi L, Honnorat J et al. Antiamphysin Antibodies Are Associated With Various Paraneoplastic Neurological Syndromes And Tumours. Arch Neurol 1999; 56(2):172-177

45 Templeton P, Caskey C, Zerhouni E. Current uses of CT and MR imaging in the staging of lung cancer. Radiol Clin North Am 1990; 28:631-646

46 Hughes J. 18F-fluorodeoxyglucose PET scans in lung cancer. Thorax 1996; 51(2):S16-22

47 Lacasse Y, Wong E, Guyatt G, Cook D. Transthoracic needle aspiration biopsy for the diagnosis of localised pulmonary lesions: a meta-analysis. Thorax 1999; 54(10):884-893.

48 Patterson G et al. The current role of mediastinoscopy in the evaluation of thoracic disease. J Thorac Cardiovasc Surg 1999; 118(5):894-899

49 George P. Fluorescence bronchoscopy for the early detection of lung cancer. Thorax 1999; 54(2):180-183

50 Maeno T. Satoh H. Ishikawa H. et al. Does earlier detection of lung cancer on mass screening improve outcome in younger and middle-age patients? Oncol Rep 1998; 5(5): 1217-1219

51 Melamed M, Flehinger B, Zamar M et al. Screening for early lung cancer. Results of the Memorial Sloan-Kettering study in New York. Chest 1984; 86, 44-53

52 Fontana R, Sanderson D, Woolner L et al. lung cancer screening: The Mayo Program. J Occup Med 1986; 28:746-50

53 Henschke C, McCauly D, Yakelevitz D et al. Early lung cancer Action Project: overall design and findings from baseline screening. Lancet 1999; 354:99-105

55 Mountain C. Revisions in the International System for Staging lung cancer. Chest 1997; 111(6):1710-1717

56 Mountain C. Clinical Biology of small cell carcinoma. Relationship to surgical therapy. Semin Oncol 1978; 5:272-9

57 Non-small cell lung cancer collaborative Group: Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised controlled trial. BMJ 1995; 311:899-909

58 Hardy J, Noble T, Smith I. Symptom relief with moderate dose chemotherapy (mitomycin-C, vinblastine and cisplatin) in advanced non-small cell lung cancer. Br J Cancer 1989; 60(5):764-766

59 Burkitt H, Quick C, Gatt D. Essential Surgery: problems, diagnosis and management. Churchill Livingstone 2^nd ed. London: 1996

60 National Cancer Institute. Physician Data Query: Treatment: Non Small Cell lung cancer.

61 Edell E, Cortese D. Photodynamic therapy in the management of early superficial squamous cell carcinoma as an alternative to surgical resection. Chest 1992; 102(5):1319-1322

62 Gauden S, Ramsay J, Tripeony L. The curative treatment by radiotherapy alone of stage I non-small cell carcinoma of the lung. Chest 1995; 108(5):1278-1282

63 PORT meta-analysis Trialists Group: Postoperative radiotherapy in non-small cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. Lancet 1998; 352(9124):257-263

64 Komaki R, Cox J, Hartz A et al. Characteristics of long-term survivors after treatment for inoperable carcinoma of the lung. Am J Clin Oncol 1985; 8(5):362-370

65 Johnson D, Einhorn L, Bartolucci A et al. Thoracic radiotherapy does not prolong survival in patients with locally advanced, non-resectable non-small cell lung cancer. Ann Intern med 1990; 113(1):33-38

66 Komaki R, Mountain CF, Holbert J et al. Superior Sulcus Tumours: Treatment Selection And Results For 85 Patients Without Distant Metastasis (M0) At Presentation. Int J Radiat Oncol Biol Phys 1990; 19(1):31-36

67 Van Raemdock D, Schneider A Ginsberg R: surgical treatment for higher stage non-small cell lung cancer. Ann Thorac Surg 1992; 54(5):999-1013

69 Ajedi A, Marks R, Bonner J. Current guidelines for the Management of Small Cell lung cancer. Mayo Clin Proc 1999; 74(8):809-816

70 Zelen M. Keynote address on biostatistics and data retrieval. Cancer Chemother Rep 1973; 4(2):31-42

71 Arrigada R, LeChevalier T, Borie F et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. J Natl Cancer Inst. 1995; 87:183-190

72 Salgia R, Skarin A, Elias A. Management of limited stage small-cell lung cancer. Adv Oncol. 1996; 12:8-15

73 The ATBC Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330:1029-1035.

74 Omenn GS, Goodman GE, Thornquist M, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996; 334:1150-1155

75 Pastori U, Infante M, Maioli M et al. Adjuvant treatment of stage I lung cancer with high-dose vitamin A. J Clin Oncol 1993; 11(7):1216-1222

76 Lippman S. University of Texas – MD Anderson Cancer Center: Phase III, Double Blind, Randomized Controlled trial of 13-CRA vs placebo to prevent second primary tumours in Patients with Totally resected Stage I non-small cell lung cancer (Sumary last modified 07/97), MDA-ID-91025, clinical trial, closed, 04/09/1997.

77 O’Neill B, Fallon M. ABC of palliative care: Principles of palliative care and pain control. British Medical Journal 1997; 315:801-804

78 Sarafino P. Health Psychology: biopsychosocial interactions 3^rd ed. Chichester: Wisley, 1998.

79 The effect of psychosocial factors on lung cancer mortality at one year. Stavraky K, Donner A, Kincade J, Stewart M. J Clin Epidemil 1999; 41(1):75-82

80 Kubler-Ross, E. On Death and Dying. London: Tavistock, 1970

81 Raw M, McNeill A, West R. Smoking Cessation Guidelines for Health Professionals: A guide to effective smoking cessation interventions for the health care system. Thorax 1998; 53(5S):1S-19S

82 Al-Moundhri M, O'Brien M, Souberbielle B. Immunotherapy of lung cancer. Br J Cancer 1998; 78(3):282-288